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SEVERE ACUTE RESPIRATORY SYNDROME: 
DESCRIPTION, EPIDEMIOLOGY AND 
CONTROL MEASURES 
Jorge E. Galva, J.D., M.H.A. 
The University of Iowa Hospitals and Clinics 
Iowa City, Iowa, U.S.A. 
Severe Acute Respiratory Syndrome (hereinafter SARS) is the first severe and readi -
ly transmissible new disease to emerge in the 21st century 1. The presence of this infec-
tious agent was first recognized in early November 2002 in the province of Guangdong 
in the People's Republic of China. SARS rapidly spread from there to other parts of the 
world, notably Southeast Asia and Canada. According to data compiled in August 
2003, altogether 8,422 cases occurred in 29 countries. The most severely affected 
countries were China (including the Special Administrative Region of Hong Kong and 
Taiwan), Canada, Singapore and Vietnam, all of which experienced outbreaks before 
the issue of global alerts by the World Health Organization (WHO) on 12 and 15 
March, 2003. Nine hundred and eight persons died in the most affected countries, 
with only eight deaths occurring in the additional 25 countries where cases were 
reported. 
International public health authorities took immediate steps to isolate and identify 
the pathogen responsible for the atypical severe pneumonia. The coronavirus (SARS-
CoV) was ultimately identified as the pathogen responsible . Vigorous, even drastic, 
national and international public health measures contributed to the rapid control of 
the infection. On July 5, 2003, WHO announced that the last known chain of human-
to-human transmission of the SARS virus had been broken; this brought to an end the 
initial outbreak of this new and severe respiratory disease2. International public health 
organizations remain alert to the possibility of re -emergence of the virus despite the 
subsidence and eventual disappearance of new infection reports. 
There exist ample unknown elements to the SARS outbreak. Epidemiologists have 
yet to definitely ascertain the origin of the pathogen, the precise mechanism of infec-
tion and the possible seasonality or environmental conditioners to re -emergence. Public 
health authorities were able to contain the outbreak through extremely successful albeit 
low-tech methods; these were greatly effective but exacted tremendous economic and 
personal hardship and disruption to millions of persons. The possibility of preventive 
measures such as vaccines is still remote. 
The SARS outbreak is a prime example of the sudden emergence of a suspected 
trans-species pathogen able to survive within the human host with extremely prejudicial 
effects on human health. Careful analysis of the appearance, detection, alert and reme-
dial methods used to control the SARS epidemic remain of the utmost importance. 
BACKGROUND OF THE DISEASE 
The first known case of atypical pneumonia occurred in Foshan City, Guangdong 
Province, People's Republic of China on November 16, 2002. WHO received reports 
of the Chinese Ministry of Health of an outbreak in that province with 305 known 
cases and five fatalities on February 11, 2003. The Chinese government informed 
WHO on February 12, 2003, that the outbreak had now affected six municipalities; 
tests for influenza viruses had come negative. Further investigations over the course of 
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t h e  n e x t  t w o  d a y s  r u l e d  o u t  t h e  p o s s i b i l i t y  o f  o t h e r  s i m i l a r  d i s e a s e s  l i k e  a n t h r a x ,  p u l -
m o n a r y  p l a g u e ,  l e p t o s p i r o s i s  a n d  h e m o r r h a g i c  f e v e r .  T h e  C h i n e s e  p u b l i c  h e a l t h  a u t h o r -
i t i e s ,  f o r  t h e  f i r s t  t i m e ,  d e s i g n a t e d  t h e  d i s e a s e  a s  a t y p i c a l  p n e u m o n i a  o f  u n k n o w n  o r i g i n  
O n  F e b r u a r y  2 0 ,  H o n g  K o n g  o f f i c i a l s  i n f o r m e d  W H O  o f  a n  o u t b r e a k  o f  t w o  c a s e s  
o f  a v i a n  i n f l u e n z a  f o l l o w i n g  t h e  d e t e c t i o n  o f  A ( H S N l )  v i r u s  i n  m e m b e r s  o f  a  f a m i l y  
r e c e n t l y  r e t u r n e d  f r o m  G u a n g d o n g .  O n  F e b r u a r y  2 6 ,  a  f o r e i g n  b u s i n e s s m a n  w a s  
a d m i t t e d  t o  t h e  F r e n c h  H o s p i t a l  i n  H a n o i ,  R e p u b l i c  o f  V i e t n a m ,  w i t h  a  t h r e e - d a y  h i s -
t o r y  o f  r e s p i r a t o r y  s y m p t o m s ;  t h e  p a t i e n t  h a d  b e e n  o n  a  b u s i n e s s  t r i p  t o  H o n g  K o n g .  
T w o  d a y s  l a t e r  D r .  C a r l o  U r b a n i ,  a  W H O  o f f i c i a l  b a s e d  i n  V i e t n a m ,  w a s  a l a r m e d  b y  
s e v e r a l  c a s e s  o f  a t y p i c a l  p n e u m o n i a  i n  t h e  F r e n c h  H o s p i t a l ,  w h e r e  h e  a s s i s t e d  a s  c o n -
s u l t a n t ;  D r .  U r b a n i  n o t i f i e d  t h e  W H O  R e g i o n a l  O f f i c e  f o r  t h e  W e s t e r n  P a c i f i c .  
O n  M a r c h  1 ,  2 0 0 3 ,  a  f o r m e r  f l i g h t  a t t e n d a n t  w a s  a d m i t t e d  t o  a  h o s p i t a l  i n  
S i n g a p o r e  w i t h  d i a g n o s i s  o f  r e s p i r a t o r y  s y n d r o m e  o f  u n k n o w n  o r i g i n .  T h e  f l i g h t  a t t e n -
d a n t  h a d  b e e n  o n  a  t r i p  t o  H o n g  K o n g .  F o u r  d a y s  l a t e r ,  t h e  b u s i n e s s m a n  h o s p i t a l i z e d  
i n  H a n o i  w a s  t r a n s f e r r e d  t o  t h e  P r i n c e s s  M a r g a r e t  H o s p i t a l  i n  H o n g  K o n g ;  b y  t h e n ,  
s e v e n  h e a l t h  w o r k e r s  a t  t h e  F r e n c h  H o s p i t a l  h a d  b e c o m e  i l l  w i t h  a t y p i c a l  p n e u m o n i a .  
O n  t h a t  s a m e  d a y  a  T o r o n t o  w o m a n  r e t u r n i n g  t o  C a n a d a  a f t e r  a  t r i p  t o  H o n g  K o n g  
d i e d ;  f i v e  m e m b e r s  o f  h e r  f a m i l y  w e r e  f o u n d  t o  b e  i n f e c t e d  a n d  w e r e  a d m i t t e d  f o r  h o s -
p i t a l  c a r e .  O n  M a r c h  1 1 ,  D r .  U r b a n i  d e p a r t e d  f o r  B a n g k o k  f o r  a  p r e s e n t a t i o n  o n  t r o p i -
c a l  d i s e a s e s ;  h e  w a s  i l l  o n  a r r i v a l  a n d  w a s  i m m e d i a t e l y  h o s p i t a l i z e d 5 .  I n  t h e  a f t e r m a t h  o f  
t h e  e p i d e m i c ,  p u b l i c  h e a l t h  a u t h o r i t i e s  d e t e r m i n e d  t h a t  t h e  v i r u s  s p r e a d  f r o m  i t s  o r i g i -
n a l  p o i n t  o f  p r e s u m e d  i n c e p t i o n  i n  G u a n g d o n g  p r o v i n c e  t o  t h e  f o l l o w i n g  c o u n t r i e s  o r  
r e g i o n s  ( i n  o r d e r  o f  d e t e c t i o n  a n d / o r  r e p o r t i n g ) :  G u a n g d o n g  p r o v i n c e ,  H o n g  K o n g ,  
V i e t n a m ,  S i n g a p o r e ,  G e r m a n y ,  C a n a d a ,  H o n g  K o n g  ( s e c o n d a r y ) ,  t h e  U n i t e d  S t a t e s  
a n d  I r e l a n d 2 :  
O n  M a r c h  1 2 ,  2 0 0 3 ,  W H O  i s s u e d  a  g l o b a l  a l e r t  a b o u t  c a s e s  o f  s e v e r e  a t y p i c a l  
p n e u m o n i a  f o l l o w i n g  m o u n t i n g  a n d  i n c r e a s i n g l y  a l a r m i n g  r e p o r t s  o f  c a s e s  a m o n g  h o s -
p i t a l  s t a f f  m e m b e r s  i n  H a n o i  a n d  H o n g  K o n g .  T h e  n e x t  d a y  W H O  a c t i v a t e d  i t s  e m e r -
g e n c y  a l e r t  s y s t e m ,  s e n d i n g  u r g e n t  m e s s a g e s  t o  a l l  G l o b a l  O u t b r e a k  A l e r t  a n d  R e s p o n s e  
N e t w o r k  ( G O A R N )  p a r t n e r s .  G O A R N  w a s  l a u n c h e d  i n  2 0 0 0  a s  a  m e c h a n i s m  t o  l i n k  
t o g e t h e r  1 1 2  e x i s t i n g  n e t w o r k s  w h i c h  p o s s e s s e d  m u c h  o f  t h e  d a t a ,  e x p e r t i s e  a n d  s k i l l s  
t o  k e e p  t h e  i n t e r n a t i o n a l  c o m m u n i t y  a b r e a s t  o f  o u t b r e a k s  a n d  r e a d y  t o  r e s p o n d .  
G O A R N  w o u l d  t u r n  o u t  t o  b e  o n e  o f  t h e  m o s t  i m p o r t a n t  i n s t r u m e n t s  i n  c o m b a t i n g  
t h e  r a p i d l y  s p r e a d i n g  d i s e a s e .  T h e  G O A R N  a l e r t  r e p r e s e n t e d  t h e  f i r s t  g l o b a l  r e c o g n i -
t i o n  o f  t h e  s e v e r e  n a t u r e  o f  t h i s  d e a d l y  t h r e a t .  W H O  w a s  o n  t h e  t r a c k  o f  a  n e w  a n d  
h i g h l y  c o n t a g i o u s  f o r m  o f  p n e u m o n i a .  T h e  r a c e  t o  s t o p  t h e  d i s e a s e  h a d  s t a r t e d .  
C A S E  D E F I N I T I O N :  
T h e  p u b l i c  h e a l t h  r e s p o n s e  t o  S A R S  d e p e n d e d  o n  t h e  r a p i d  d e v e l o p m e n t  o f  m e a n s  
t o  p r o m p t l y  i d e n t i f y  s u s p e c t  c a s e s  a n d  d i f f e r e n t i a t e  t h e s e  f r o m  k n o w n  e n t i t i e s  w i t h  s i m -
i l a r  s y m p t o m s .  I n  o r d e r  t o  d o  t h i s ,  i n f o r m a t i o n  w a s  r a p i d l y  s h a r e d  b y  a l l  W H O  p a r t n e r s  
r e p o r t i n g  S A R S  a n d  S A R S - l i k e  v i c t i m s .  A  c a s e  d e f i n i t i o n  w a s  d e v e l o p e d  s e v e r a l  m o n t h s  
a f t e r  t h e  o n s e t  o f  t h e  e p i d e m i c .  T h e  C e n t e r s  f o r  D i s e a s e  C o n t r o l  (  C D C )  d e f i n e d  a  s u s -
p e c t  c a s e  o f S A R S  a s  a  p e r s o n  w i t h  o n s e t  o f  f e v e r  ( t e m p e r a t u r e  > 3 8 ° C  [ 1 0 0 . 4 ° F ] )  a n d  
l o w e r  r e s p i r a t o r y  t r a c t  s y m p t o m s  w i t h i n  l  O  d a y s  o f  e i t h e r  t r a v e l  t o  a n  a r e a  w i t h  d o c u -
m e n t e d  t r a n s m i s s i o n  o f  S A R S  o r  c l o s e  c o n t a c t  w i t h  a  p e r s o n  b e l i e v e d  t o  h a v e  S A R S .  A  
p r o b a b l e  c a u s e  w a s  d e f i n e d  a s  a  s u s p e c t  c a s e  t h a t  a l s o  h a s  c h e s t  r a d i o g r a p h i c  f i n d i n g s  o f  
p n e u m o n i a ,  a c u t e  r e s p i r a t o r y  d i s t r e s s  ( A R D S ) ,  o r  a n  u n e x p l a i n e d  r e s p i r a t o r y  i l l n e s s  
r e s u l t i n g  i n  d e a t h ,  w i t h  a u t o p s y  f i n d i n g s  o f  A R D S  w i t h o u t  i d e n t i f i a b l e  c a u s e .  S u s p e c t  
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and probable cases were further classified based on laboratory findings as laboratory 
positive, laboratory negative or indeterminate, as shown in the following table 6: 
Table 1. C : ,e:nte-r s ·:for D ·b;;ease Con-trol aucl Pre,ren.iion 
Case Definition. for SAR.S.J.,.-1 -w 
C linic a l cri t eri .a 
Asyn'lpto1:nat-1c or 1.n:i.ld respiratory :illness 
'Moderate r es pi.J.<2tt·ory i.l.h"l.e ,ss 
Te1n.peranu e ::::.~t00 .4-IF ( > ·3 8IC) and 
Ch.."l.e or 1:n o 1·e c linical fin.din.gs of' r espi.raroi:y .illness (eg .. co u gh. . 
s h.ortuoe-ss o.f breath . di:f'fic.ult y witlJ. brcatli.ing. or .hypoxia) 
Se-,.,·c1te 1·cs:pirato1-y dlne .s..c; 
Ten:iperature :.'.> 1.00
_
4")F ( >381'.C) nnd 
One 01· ruorc clin ..ica.l findi.n g,'S 0£ rcsp.ir artory illnc- ·ss (eg ... cough. 
shortness olbrcnth.. d i.fficu .lt:y '\..Vit.b breathin g ~ OT hypoxia) 
AND 
R..a.diog raphi c c, ·ideuc..e of pnc"l.u:uonia or 
A"R.DSor 
Aut.o-psy findn~gs co:n si."!it ent '\.vitb pu.eu:rnonia or ARDS '"1'ithout a.a'.l 
idei:itifiabl e cause 
Epidelllioiogical criteria 
Tra,:el (including transi t in an airport) ,•vidtin 10 clays 0£ on.set -0£ 
s,--n-:ipto:1
:n
s. to a.n area ,vit.b current. or r ·ccent.l y docu.n:1.e:a:it-ed or 
s.u spe-c t e d community trans. rn.issio u. of SARSj 
OR 
Clo,">e con.tact ,,.vi thin 10 d.a-ys of" onset of' .sy1npton:LS "vith a per.so n 
k:no,vn or su.spectcd ~o have SARS in.fection 
L.abor'a tory crit-..eri21 
Con.finned 
D e t ection. 0£ a ·nt:ibody t.o SARS -C-o Vin spec-lln.en.s obta.l n-ed durin g 
acu~ i.Uness or > 2 1 da.y s after tllness onset o r 
D e tectio n. 0£SARS -C.-0V RNA by RT- PCR confirmed bya secon d 
PCR as:say. by u sing a second <'lliqu.ot ot~ the s pecin.1.en and a 
diffe rent se t of- PCR pri:r:ners or 
I so lation. 0£ S ARS -Co'-' 
Negative 
Absence of antibody t o SARS- CoV in cou.va:l escen. t se, .ru:n.'.l 
obt.aii1.ed > 2 1 days after sympt.01-n. on.set 
U ndet:ennined 
L.abornt-0.ty' testing e-i ther u.ot perfonned or .iucoinple te 
Case clas
.s
ifi cat .ion 
Pro b.abl e cnse 
Me-ets d:i.e clinical c.ritei"ia £or .s:eve-1:-e res p.i.rat .ory .illne,ss of' 
1..uUCnovv:n etio
l
ogy v..rirh on.~t :c...ince Nove.n1beI · 1 . 2002_ a nd 
e picleu:i.iologica l cri teria ; lahorat:ory crit.e-1:ia confinnecl,. negati....-e . 
or undet:en:nined 
S u spe,c t c.ase 
M e,ets th .e clinical criteria f'or 1:u.oden1.t .e res:pira'tory .illne.gs: oC 
1..u:iknO
"
'-'Vn . etiol ogy "-Virh. on.sa:~·t since Nove.n :1he'I · 1 . 2002 .. a nd 
,epide.n.-:aiolog:ica.1 cri teria -;. l abcn:a tory cr it-c=..ria confuTUed . n.e -gat.ive ~ 
o r undet..errn.inecl 
*ARDS = acute l'"e"spirn.tcny di strcs: s syndrome : RT -PCR = r eve rse-trau-
scriptas:e poly :1 :neras.e c hain reactiou. ; SARS = seve:r-c- acute res.pira.t o-ry 
sy:n.clro :1.ne ; SARS- CoV = SARS cor on.a,"l'rus _ 
t Trave:l crik'rin £or suspect or probable US c a ses. of SAR.S- . Last date of 
illn
e
ss 01"'J.5e t £or i.n.c h :u;ion as 21. r eport .ed case : Chi n.a (n:ia.inlan.d) . Hon g 
Kong., Tn..i"va..n.. To-i-on.to.,. o n goi ng; Hanoi _, '\li etnan::a. ~ 1'v1a y 2 5 ~ 2 003 ; 
S ingapore ~ June 4 ~ 2003 . 
T he rapid collection and classification of data during and after the epidemic subsided 
has allowed the refin ement of those indicators to include further description of clinical, 
physical, laboratory and radiographic findings7: 
1. Clinical Signs and Symptoms: The median incubation period for SARS appeared to 
be four to six days, with most patients becoming ill within two to 10 days after 
exposure. The most common symptoms were fever, often accompanied by headache, 
myalgia, malaise , chi lls and rigor. The mai n component of SARS, respiratory symp-
toms, typically did not begin until after two to seven days after illness onset. The 
most common respiratory symptoms were lower respiratory tract symptoms, includ-
ing cough and dyspnea. Gastrointestinal symptoms were reported in some cases . 
2 . Physical findings : the most frequent physical findings were tachypnea, tachycardia 
and hypoxemia . Although fever was commonly associated with SARS (to the exte nt 
that some public buildings rapidly acq uired and installed automatic body tempera-
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t u r e  m e a s u r i n g  d e v i c e s  a t  t h e i r  e n t r i e s ) ,  a s  m a n y  a s  1 5 - 4 4  p e r c e n t  h a d  a  n o r m a l  
b o d y  t e m p e r a t u r e  u p o n  e v a l u a t i o n ,  e v e n  t h o u g h  o t h e r  s y m p t o m s  o f  S A R S  w e r e  
a l r e a d y  p r e s e n t .  
3 .  L a b o r a t o r y  f i n d i n g s :  h e m a t o l o g i c  a b n o r m a l i t i e s  w e r e  a m o n g  t h e  m o s t  c o n s i s t e n t  l a b -
o r a t o r y  f i n d i n g s  r e p o r t e d  i n  S A R S  p a t i e n t s ;  m o s t  p a t i e n t s  h a d  t o t a l  l e u k o c y t e  c o u n t s  
t h a t  w e r e  n o r m a l  o r  s l i g h t l y  l o w ,  a n d  7 0 - 9 5  p e r c e n t  o f  p a t i e n t s  h a d  l y m p h o p e n i a .  
P l a t e l e t  c o u n t s  w e r e  m i l d l y  d e p r e s s e d  i n  3 0 - 5 0  p e r c e n t  o f  a l l  p a t i e n t s ,  a n d  p r o l o n g a -
t i o n  o f  t h e  a c t i v a t e d  p a r t i a l  t h r o m b o p l a s t i n  t i m e  w a s  o b s e r v e d  i n  4 0 - 6 0  p e r c e n t  o f  
p a t i e n t s ;  o t h e r  c o m m o n  l a b  a b n o r m a l i t i e s  i n c l u d e d  e l e v a t e d  l a c t a t e  d e h y d r o g e n a s e  i n  
7 0 - 9 0  p e r c e n t  o f  p a t i e n t s ,  e l e v a t e d  a l a n i n e  a m i n o t r a n s f e r a s e  l e v e l s  i n  2 0 - 3 0  p e r c e n t ,  
a n d  e l e v a t e d  c r e a t i n e  p h o s p h o k i n a s e  i n  3 0 - 4 0  p e r c e n t  o f  a l l  p a t i e n t s .  
4 .  R a d i o g r a p h i c  f i n d i n g s :  A v a i l a b l e  d a t a  s u g g e s t s  t h a t  a l m o s t  a l l  r e p o r t e d  S A R S  p a t i e n t s  
w i t h  l a b o r a t o r y  e v i d e n c e  o f  S A R S - C o V  i n f e c t i o n  h a v e  r a d i o g r a p h i c  e v i d e n c e  o f  
p n e u m o n i a  d o c u m e n t e d  a t  s o m e  p o i n t  d u r i n g  t h e i r  i l l n e s s .  H o w e v e r ,  a p p r o x i m a t e l y  
3 0  p e r c e n t  o f  c h e s t  X - r a y s  m a y  b e  n o r m a l  a t  t h e  t i m e  o f  f i r s t  e v a l u a t i o n  d e s p i t e  
o n s e t  o f  s y m p t o m s .  A g g r e g a t e d  d a t a  s u g g e s t e d  t h e  p r e s e n c e  o f  r a d i o g r a p h i c  e v i -
d e n c e  o f  S A R S - C o  V  i n  9 7  p e r c e n t  o f  a l l  p a t i e n t s  a t  d a y  s e v e n  o f  o n s e t  o f  s y m p t o m s .  
C T  a p p e a r e d  t o  b e  a  m o r e  s e n s i t i v e  i n s t r u m e n t  t h a n  c o n v e n t i o n a l  X - r a y s ;  S A R S  
p a t i e n t s  w h o  h a d  n o r m a l  X - r a y s  e a r l y  i n  t h e i r  c l i n i c a l  c o u r s e  o f t e n  h a d  e v i d e n c e  o f  
p n e u m o n i a  b y  C T .  
5 .  C l i n i c a l  v i r o l o g y :  T h e  m a i n  l a b o r a t o r y  t e s t s  a v a i l a b l e  t o  d i a g n o s e  S A R S - C O V  i n f e c -
t i o n  u t i l i z e d  b y  p u b l i c  h e a l t h  a u t h o r i t i e s  a s  a  r e s p o n s e  t o  t h e  e p i d e m i c  w e r e  R N A  
d e t e c t i o n  t h r o u g h  r e v e r s e  t r a n s c r i p t a s e - p o l y m e r a s e  c h a i n  r e a c t i o n  ( R T - P C R )  o r  r e a l -
t i m e  P C R  a n d  s e r o l o g i c  t e s t i n g  f o r  a n t i b o d i e s  a g a i n s t  S A R S - C o V 8 .  D e s p i t e  t h e  d i s -
p u t e s  r e g a r d i n g  t h e  r e l i a b i l i t y  o f  P C R  t e s t s  f o r  S A R S - C o V  d e t e c t i o n ,  t h e  c l i n i c a l  
m e a n s  h a s  b e e n  e n d o r s e d  b y  o t h e r  s t u d i e s 9 .  T h e  C D C  h a s  e n d o r s e d  t h e  u s e  o f  R T -
P C R  a s  a  m e a n s  o f  d e t e c t i o n  o f  S A R S - C o V  i n f e c t i o n .  T h i s  i s  w o r k i n g  d e f i n i t i o n  
u s e d  b y  t h e  C D C l O :  
A .  L a b o r a t o r y  c o n f i r m e d  S A R S - C o V  
•  D e t e c t i o n  o f  a n y  o f  t h e  f o l l o w i n g  b y  a  v a l i d a t e d  t e s t ,  w i t h  c o n f i r m a t i o n  i n  a  
r e f e r e n c e  l a b o r a t o r y :  
•  S e r u m  a n t i b o d i e s  t o  S A R S - C o V  i n  a  s i n g l e  s e r u m  s p e c i m e n ,  o r  
•  A  f o u r - f o l d  i n c r e a s e  i n  S A R S - C o V  a n t i b o d y  t i t e r  b e t w e e n  a c u t e  a n d  c o n v a -
l e s c e n t - p h a s e  s e r u m  s p e c i m e n s  t e s t e d  i n  p a r a l l e l  o r  
•  I s o l a t i o n  i n  c e l l  c u l t u r e  o f  S A R S - C o V  f r o m  a  c l i n i c a l  s p e c i m e n ,  w i t h  c o n f i r -
m a t i o n  u s i n g  a  t e s t  v a l i d a t e d  b y  C D C  o r ;  
•  D e t e c t i o n  o f  S A R S - C o V  R N A  b y  R T - P C R  v a l i d a t e d  b y  C D C ,  w i t h  c o n f i r -
m a t i o n  i n  a  r e f e r e n c e  l a b o r a t o r y ,  f r o m :  
•  T w o  c l i n i c a l  s p e c i m e n s  f r o m  d i f f e r e n t  s o u r c e s ,  o r  
•  T w o  c l i n i c a l  s p e c i m e n s  c o l l e c t e d  f r o m  t h e  s a m e  s o u r c e  o n  t w o  d i f f e r e n t  
d a y s  
T h e  C D C  h a s  d e v e l o p e d  a n d  v a l i d a t e d  a n  e n z y m e  i m m u n o a s s a y  ( E I A )  f o r  d e t e c t i o n  o f  
s e r u m  a n t i b o d y  t o  S A R S - C o V  a n d  a n  R T - P C R  a s s a y  f o r  d e t e c t i o n  o f  S A R S - C o V .  T h e  
C D C ,  h o w e v e r ,  c o n s i d e r s  d e t e c t i o n  o f  t h e  S A R S - C o V  a n t i b o d y  t h e  m o s t  r e l i a b l e  i n d i -
c a t o r  o f  t h e  i n f e c t i o n  1 1 .  
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EPIDEMIOLOGY: 
Tacking the causative agent of disease and route(s) of transmission: 
Despite the development of this array of indicators, detection of the SARS-CoV 
infection mainly remains in the realm of epidemiological investigation. As with other 
causes of bacterial and viral pneumonia, clinical findings in patients with SARS cannot 
accurately predict the causative agent. Additional refinements in the detection of the 
causative agent are required to determine whether the constellation of clinical findings 
alone can be used to discriminate accurately between SARS and other respiratory dis-
eases . Many of the clinical and laboratory features of SARS are similar to other forms of 
viral pneumonia. This makes tracking suspect SARS cases and determining routes of 
infection a complicated taskl2. 
Once again the rapid public health response all owed the collection and dissemination 
of crucial information allowing the identification of probable cases and routes of trans-
mission . The fo llowing information has been validated through repeated epidemiologi -
cal observation over the course of the epidemic and its aftermathl3: 
I. Direct contact: the fact that the majority of new infections occurred in close contact 
of patients, such as household members, healthcare workers or other patients not 
protected, indicates that the virus is predominantly spread by droplets or by direct 
and indirect contact. Airborne spread of SARS, however, does not seem to be a 
major route of transmission, despite conflicting evidence linked to the apparent air-
borne transmission in the Hong Kong/Hotel Metropole infection cluster. T here are 
currently no indications that any goods, products or animals arriving from areas with 
SARS outbreaks pose a risk to public health, leading the WHO to not recommend 
any restriction in animal movement from epidemic zones. 
2 . Asymptomatic patients: There are few data as to asymptomatic individuals can trans-
mit the infection . Preliminary findings suggest that developers of mild symptoms 
may have the SARS-CoV antibodies without developing SARS. There is at present 
no direct evidence of contagion from an asymptomatic patient. 
3. Symptomatic patients: The weight of evidence suggests that only symptomatic 
patients may spread the SARS virus efficiently. However, earl y evidence from 
Singapore suggests that the rate of transmission, though considerable, is not explo-
sive: 81 percent of all probable SARS cases in Singapore had no evidence of trans-
mission of a clinicall y identifiable ill ness to other persons. In comparison with other 
infectious diseases that are spread via the respiratory route, SARS seems to be mod -
erate ly transmissible. 
4. Superspreaders: The term "superspreading" has been used to describe situation in 
which a single individual has d irectly infected a large number of other individuals. In 
the Singapore epidemic, of the first 201 probable cases reported, 103 were infected 
by just five source cases. The most probable explanatio n for the phenomenon of 
superspreading is extensive viral shedding by the patients . This may be due to 
advanced disease or possibly co-morbidities that result in high viral loads. However, 
there is need of additional data to come to definite conclusions in order to under-
stand why, under certain circumstances, the spread of SARS is extremely efficient. 
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5 .  H i g h - r i s k  a c t i v i t i e s :  T h e  r a p i d  s p r e a d  o f  S A R S  a m o n g  h e a l t h c a r e  w o r k e r s  i n  H a n o i ,  
V i e t n a m  a n d  i n  H o s p i t a l  i n  H o n g  K o n g  c o n f i r m e d  t h e  p o t e n t i a l l y  h i g h l y  c o n t a g i o u s  
n a t u r e  o f  t h e  v i r u s .  M e d i c a l  p e r s o n n e l ,  p h y s i c i a n s ,  n u r s e  a n d  h o s p i t a l  w o r k e r s  a r e  
a m o n g  t h o s e  c o m m o n l y  i n f e c t e d .  A t t a c k  r a t e s  a s  h i g h  a s  5 0  p e r c e n t  h a v e  b e e n  
r e p o r t e d .  I n  p a r t i c u l a r ,  d i a g n o s t i c  a n d  t h e r a p e u t i c  p r o c e d u r e s  i n s i d e  t h e  h o s p i t a l s ,  
s u c h  a s  d i a g n o s t i c  s p u t u m  i n d u c t i o n ,  b r o n c h o s c o p y ,  e n d o t r a c h e a l  i n t u b a t i o n ,  a n d  
a i r w a y  s u c t i o n  a r e  p o t e n t  a e r o s o l  g e n e r a t i n g  p r o c e d u r e s ,  a n d  a r e  n o w  r e c o g n i z e d  a s  
h i g h - r i s k  a c t i v i t i e s .  T h e  h i g h - r i s k  n a t u r e  o f  a c t i v i t i e s  g e n e r a t i n g  p o t e n t  a e r o s o l  
p o t e n t i a l  i s  v a l i d a t e d  b y  t h e  r e c e n t l y  p u b l i c i z e d  o u t b r e a k  o f  S A R S  a f f e c t i n g  l a b  w o r k -
e r s  i n  C h i n a l 4 .  
6 .  T r a n s m i s s i o n  d u r i n g  q u a r a n t i n e :  T h e r e  h a s  b e e n  a t  l e a s t  o n e  r e p o r t  o f S A R S - C o V  
t r a n s m i s s i o n  d u r i n g  q u a r a n t i n e .  T h i s  i n d i c a t e d  t h e  r i s k  o f  g r o u p i n g  s u s p e c t e d  S A R S  
c a s e s  w i t h  r e a l  S A R S  c a s e s  i n  t h a t  t h e  u n i n f e c t e d  i n d i v i d u a l  m a y  b e c o m e  i n f e c t e d  
d u r i n g  t h e  i s o l a t i o n  a n d  q u a r a n t i n e  p e r i o d .  
7 .  F i n a l  o b s e r v a t i o n s :  T h e  S A R S  v i r u s  i s  n o t  e a s i l y  t r a n s m i s s i b l e  o u t s i d e  o f  c e r t a i n  s e t -
t i n g s .  F o r  a  m a j o r  l o c a l  o u t b r e a k  t o  o c c u r  t h e r e  n e e d s  t o  b e :  
A .  A n  i n f e c t i o u s  p a t i e n t ,  a n d  
B .  A  c l o s e  c o m m u n i t y  o r  " t r i b e , "  i . e . ,  h e a l t h c a r e  w o r k e r s ,  m i l i t a r y  p o p u l a t i o n s ,  
t r a v e l  g r o u p s ,  r e l i g i o u s  g a t h e r i n g s  o r  f u n e r a l s ,  w i t h  c l o s e  i n t e r a c t i o n s .  
T h e  f o r e g o i n g  s u g g e s t s  t h e  c r u c i a l  i m p o r t a n c e  o f  a p p r o p r i a t e  t r a c k i n g  a n d  l i n k a g e  o f  
s u s p e c t e d  a n d  p r o b a b l e  S A R S  p a t i e n t s ,  a n d  s t r i c t  p r e v e n t i v e  a n d  r e m e d i a l  m e a s u r e s .  
T h e s e  w i l l  b e  d i s c u s s e d  i n  a  s u b s e q u e n t  s e c t i o n  o f  t h i s  p a p e r .  
A T T A C K  R A T E S :  
E v e n  t h o u g h  s e v e r a l  e s t i m a t i o n s  o f  S A R S - C o V  a t t a c k  r a t e s  h a v e  b e e n  m a d e  b y  
p u b l i c  h e a l t h  a u t h o r i t i e s  w o r l d w i d e ,  a  s t u d y  p u b l i s h e d  i n  t h e  N E J M  u s i n g  c a s e s  a n d  
c o n t r o l s  t r a v e l i n g  i n  a i r p l a n e s  w i t h  k n o w n  S A R S - i n f e c t e d  i n d i v i d u a l s  i s  v e r y  c o m p e l l i n g  
d u e  t o  t h e  b u i l t - i n  c o n t r o l  f o r  c o n f o u n d i n g  f a c t o r s .  T h e  r e s e a r c h e r s  c h o s e  t h r e e  d i f f e r -
e n t  i n s t a n c e s  w h e r e  a i r l i n e  p a s s e n g e r s  w e r e  f o u n d  t o  s i t  a t  v a r y i n g  d i s t a n c e s  t o  S A R S -
i n f e c t e d  p a t i e n t s .  T h e  r e s e a r c h e r s  c o n t r o l l e d  f o r  t h e  i n f e c t i o u s  n a t u r e  o f  t h e  i n d e x  p a s -
s e n g e r ,  p r e v i o u s  p u l m o n a r y  i n f e c t i o n s  i n  c a s e s  a n d  c o n t r o l s  o n  b o a r d  a n d  d i s t a n c e  f r o m  
t h e  s e a t i n g  p l a c e  o f  t h e  i n d e x  p a t i e n t .  A f t e r  o n e  f l i g h t  c a r r y i n g  a  s y m p t o m a t i c  p e r s o n  
a n d  1 1 9  o t h e r  p e r s o n s ,  l a b o r a t o r y - c o n f i r m e d  S A R S  d e v e l o p e d  i n  1 6  p e r s o n s ,  t w o  o t h -
e r s  w e r e  g i v e n  d i a g n o s e s  o f  p r o b a b l e  S A R S ,  a n d  f o u r  w e r e  r e p o r t e d  t o  h a v e  S A R S  b u t  
c o u l d  n o t  b e  i n t e r v i e w e d .  A m o n g  t h e  2 2  p e r s o n s  w i t h  i l l n e s s ,  t h e  m e a n  t i m e  f r o m  t h e  
f l i g h t  t o  t h e  o n s e t  o f  s y m p t o m s  w a s  f o u r  d a y s  ( r a n g e ,  t w o  t o  e i g h t ) ,  a n d  t h e r e  w e r e  n o  
r e c o g n i z e d  e x p o s u r e s  t o  p a t i e n t s  w i t h  S A R S  b e f o r e  o r  a f t e r  t h e  f l i g h t .  I l l n e s s  i n  p a s s e n -
g e r s  w a s  r e l a t e d  t o  t h e  p h y s i c a l  p r o x i m i t y  t o  t h e  i n d e x  p a t i e n t ,  w i t h  i l l n e s s  r e p o r t e d  i n  
e i g h t  o f  t h e  2 3  p e r s o n s  w h o  w e r e  s e a t e d  i n  t h e  t h r e e  r o w s  i n  f r o n t  o f  t h e  i n d e x  p a t i e n t ,  
a s  c o m p a r e d  w i t h  1 0  o f  t h e  8 8  p e r s o n s  w h o  w e r e  s e a t e d  e l s e w h e r e  (  r e l a t i v e  r i s k ,  3  . 1 ;  
9 5  p e r c e n t  c o n f i d e n c e  i n t e r v a l ,  1 . 4  t o  6 . 9 ) .  I n  c o n t r a s t ,  a n o t h e r  f l i g h t  c a r r y i n g  f o u r  
s y m p t o m a t i c  p e r s o n s  r e s u l t e d  i n  t r a n s m i s s i o n  t o  a t  m o s t  o n e  o t h e r  p e r s o n ,  a n d  n o  i l l -
n e s s  w a s  d o c u m e n t e d  i n  p a s s e n g e r s  o n  t h e  f l i g h t  t h a t  c a r r i e d  a  p e r s o n  w h o  h a d  p r e -
s y m p t o m a t i c  S A R S .  T h i s ,  i n  t u r n ,  l e a d  t o  t h e  c o n c l u s i o n  t h a t  t r a n s m i s s i o n  o f  S A R S  
m a y  o c c u r  o n  a n  a i r c r a f t  w h e n  i n f e c t e d  p e r s o n s  f l y  d u r i n g  t h e  s y m p t o m a t i c  p h a s e  o f  i l l -
n e s s .  I  5 .  
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METHOD(S) OF CONTROL/PREVENTION: 
The CD C has issued the following core recommendations as key elements for control 
and prevention o f SARS-CoV epidemic recurrence: 
1. Command and control 
a. Goals: 
1. Determine and establish operational authority for a response 
11. Establish an incident management structure for the response to a SARS 
o utbreak, suppo rted by adequate information systems 




1. Max imize earl y detection of cases and cluste rs of respiratory infections 
that might signal the global re -e mergence of SARS-Co V disease while 
minimizing unnecessary laboratory testing, implementation of control 
measures and social disruption 
11. If SARS-Co V transmission recurs, maintain prompt and complete iden-
tification and reporting of potential cases to facilitate ou tbreak control 
and management 
n1. Identi fy and monitor contacts of cases of SARS-CoV disease to enable 
earl y detection of illness in persons at greatest risk 
3. Prepared ness 
a. Goals: 
1. Rapidly identify and isolate all potential SA RS patients 
11. Implement infection control practices and contact traci ng to interrup t 
SARS-CoV transmission 
n1. Ensure rapid communication within healthcare facilities and between 
healthcare fac iliti es and health departments 
4. Community contai nment measures, including non -hospital isolatio n and quaran -
tine 
a. Goal : 
1. Prevent transmission of SARS-CoV through use of a range of commu -
nity containment strategies chosen to provide maximum efficacy based 
o n the characteristics of the o utbreak while minimi zing the adverse 
impacts o n civil liber ti es 
5. Prevention of international travel -re lated transmission risk 
a. Goals: 
1. Prevent the introduction ofSARS -CoV (and spread fro m an introduc-
tion ) into the United States from SARS-affected areas 
11. Prevent exportation of SARS-CoV from the U nited States if domestic 
t ransmissio n presents and increased risk of exportation 
n1. Red uce the risk ofSARS-CoV disease among o utbound travelers to 
SARS-affec ted areas 
1v. Prevent the transmission of SARS -CoV to passengers o n a conveyance 
with a SARS patient, and evaluate and monito r o ther passengers to 
detect SARS-like illness and prevent further spread 
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6 .  L a b o r a t o r y  D i a g n o s t i c s  
a .  G o a l s :  
i .  P r o v i d e  t h e  p u b l i c  h e a l t h  c o m m u n i t y  w i t h  r e a d y  a c c e s s  t o  h i g h - q u a l i t y  
S A R S - C o  V  d i a g n o s t i c s  
1 1 .  E n s u r e  t h a t  S A R S - C o V  l a b o r a t o r y  d i a g n o s t i c s  a r e  u s e d  s a f e l y  a n d  
a p p r o p r i a t e l y  a n d  t h a t  r e s u l t s  a r e  i n t e r p r e t e d  c o r r e c t l y  
7 .  C o m m u n i c a t i o n  a n d  E d u c a t i o n  
a .  G o a l s :  
i .  I n s t i l l  a n d  m a i n t a i n  p u b l i c  c o n f i d e n c e  i n  t h e  n a t i o n ' s  p u b l i c  h e a l t h  s y s -
t e m  
1 1 .  C o n t r i b u t e  t o  t h e  m a i n t e n a n c e  o f  o r d e r ,  m i n i m i z a t i o n  o f  p u b l i c  p a n i c  
a n d  f e a r  a n d  f a c i l i t a t i o n  o f  p u b l i c  p r o t e c t i o n  
1 1 1 .  P r o v i d e  a c r n r a t e ,  t i m e l y  a n d  c o m p r e h e n s i v e  i n f o r m a t i o n  a b o u t  t h e  
S A R S - C o  V  e p i d e m i c  a n d  d i s e a s e  
1 v .  A d d r e s s  r u m o r s ,  i n a c c u r a c i e s ,  a n d  m i s p e r c e p t i o n s  a s  q u i c k l y  a s  p o s s i b l e ,  
a n d  p r e v e n t  s t i g m a t i z a t i o n  o f  s p e c i f i c  g r o u p s  
8 .  I n f e c t i o n  c o n t r o l  i n  h e a l t h c a r e ,  h o m e  a n d  c o m m u n i t y  s e t t i n g s  
a .  G o a l s :  
i .  E n s u r e  e a r l y  r e c o g n i t i o n  o f  p a t i e n t s  a t  r i s k  f o r  S A R S - C o V  d i s e a s e  
i i .  P r e v e n t  t r a n s m i s s i o n  o f  S A R S - C o V  b y  i m p l e m e n t i n g  a p p r o p r i a t e  i n f e c -
t i o n  c o n t r o l  p r e c a u t i o n s  
9 .  I n f o r m a t i o n  t e c h n o l o g y  
a .  G o a l :  
i .  D e p l o y  a n  i n t e g r a t e d  d a t a  m a n a g e m e n t  s y s t e m  t h a t  e f f i c i e n t l y  a n d  
e f f e c t i v e l y  s u p p o r t s  S A R S  o u t b r e a k  r e s p o n s e  n e e d s  a t  t h e  f e d e r a l ,  s t a t e  
a n d  l o c a l  l e v e l s .  
T h e s e  b a s i c  m e a s u r e s  h a v e  b e e n  w i d e l y  d i s s e m i n a t e d  b y  t h e  C D C  a n d  W H O  a s  a n  e l e -
m e n t a r y  t e m p l a t e  f o r  t h e  p r o m p t  d e t e c t i o n  a n d  c o n t a i n m e n t  o f  S A R S - C o V .  
P U B L I C  H E A L T H  L A W  O B S E R V A T I O N S :  
A n  e p i d e m i c  i n v o l v i n g  S A R S - C o V  i n  t h e  U n i t e d  S t a t e s  w i l l  t e s t  t h e  l i m i t s  o f  t h e  
p u b l i c  h e a l t h  l e g a l  i n f r a s t r u c t u r e .  T h e  e v e n t u a t i o n  o f  a n  e p i d e m i c  o f  m a j o r  p r o p o r t i o n s  
w o u l d  f o r c e  p u b l i c  h e a l t h  a u t h o r i t i e s  t o  u t i l i z e  a l l  l e g a l  m e a n s  a t  t h e i r  d i s p o s a l  t o  c o n -
t r o l  a n d  c o n t a i n  t h e  e p i d e m i c .  
T h i s  p o s s i b i l i t y  r a i s e s  s e r i o u s  q u e s t i o n s  t h a t  m u s t  b e  p r o p e r l y  a n s w e r e d  i n  o r d e r  t o  
p r e v e n t  u n n e c e s s a r y  l o s s  o f  l i f e ,  e c o n o m i c  a c t i v i t y  a n d  s o c i a l  i n t e r a c t i o n .  T w o  s o l u t i o n s  
h a v e  b e e n  p r o p o s e d :  o n e  i s  e n c o m p a s s e d  b y  t h e  M S E H P A 1 7 ,  t h e  o t h e r  b y  t h e  d e f e n d -
e r s  o f  a  m o r e  t r a d i t i o n a l  a p p r o a c h  t o  t h e  a p p l i c a t i o n  o f  s t a t e  p o l i c e  p o w e r  a s  t h e  p r o p e r  
m e a n s  t o  d e a l  w i t h  s u c h  a n  e m e r g e n c y  1 8 .  T h e  d i s c u s s i o n  r e v o l v i n g  a r o u n d  t h e s e  t w o  
d i f f e r i n g  p r o p o s a l s  i s  f a r  f r o m  t h e o r e t i c a l .  T h e  M S E H P A  p r o p o s e s  a  b a l a n c e d  a p p r o a c h  
t o  i n f e c t i o n  c o n t r o l  i n c l u d i n g  c o m p r e h e n s i v e  l e g a l  p r o t e c t i o n  t o  i n d i v i d u a l s ,  i n c l u d i n g  
c o u r t  h e a r i n g s  t o  c o n t e s t  i s o l a t i o n  a n d  q u a r a n t i n e  o r d e r s .  T h i s  m a y  r e s u l t  i n a d e q u a t e  
t o  p r o p e r l y  c o n t r o l ,  t r a c k  a n d  d e t a i n  p o t e n t i a l  s p r e a d e r s .  T h e  t r a d i t i o n a l  p o l i c e  p o w e r  
a p p r o a c h ,  o n  t h e  o t h e r  h a n d ,  o f f e r s  a  m u c h  m o r e  f l e x i b l e  r e s p o n s e  c a p a b i l i t y ,  w h i c h  
m a y  b e  h a m p e r e d  b y  a n t i q u a t e d  l a w s  a n d  j u d i c i a l  i n t e r f e r e n c e  w i t h  a d m i n i s t r a t i v e  a c t i v -
i t i e s .  
A  p r o m p t  r e s p o n s e  t o  t h i s  l e g a l  d e b a t e  i s  n e e d e d .  P u b l i c  h e a l t h  l a w  w i l l  b e  a n  
i n d i s p e n s a b l e  c o m p o n e n t  o f  a  t r u l y  e f f e c t i v e  p u b l i c  h e a l t h  r e s p o n s e  t o  S A R S .  
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CONCLUSION: 
A recent controlled outbreak of SARS highlights the critical importance of main -
taining a vigilant attitude towards this disease . Massive media have, unfortunately, 
done a poor job in properly illustrating the proper scope of the disease and the risks 
associated with it. 
Concerned governments must develop prophylactic plans to educate and sensitize 
the popu lation at large about the contagious routes, symptoms and risks of SARS. The 
almost automatic reappearance of facemasks in C hina upon preliminary suggestions of a 
renewed epidemic is a hallmark of an aware populatio n. Such measures must be 
strengthened and amplified until such time as more reliable markers of the disease are 
developed and/or an effective vaccine is produced for those populations at risk for the 
disease. 
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